Characterization of Specific Cells Using MHC Class II Tetramers Reveals Phenotypic Differences Related to HIV Infection and Tuberculosis Disease
Overview
Authors
Affiliations
A major challenge for the development of an effective vaccine against tuberculosis (TB) is that the attributes of protective CD4 T cell responses are still elusive for human TB. Infection with HIV type 1 is a major risk factor for TB, and a better understanding of HIV-induced alterations of -specific CD4 T cells that leads to failed host resistance may provide insight into protective T cell immunity to TB. A total of 86 participants from a TB-endemic setting, either HIV-infected or uninfected and with latent or active TB (aTB), were screened using -specific MHC class II tetramers. We examined the phenotype as well as function of ex vivo -specific tetramerCD4 T cells using flow cytometry. The numbers of -specific tetramerCD4 T cells were relatively well maintained in HIV-infected persons with aTB, despite severe immunodeficiency. However, although HIV-uninfected persons with latent TB infection exhibited ex vivo -specific CD4 T cells predominantly of a CXCR3CCR6CCR4 (Th1*) phenotype, aTB or HIV infection was associated with a contraction of this subset. Nevertheless, in individuals with aTB and/or HIV infection, circulating ex vivo -specific CD4 T cells did not display defects in exhaustion or polyfunctionality compared with healthy HIV-uninfected individuals with latent TB infection. Collectively, these data suggest that increased susceptibility to TB disease could be related to a loss of circulating Th1* CD4 T cells rather than major changes in the number or function of circulating CD4 T cells.
Farroni C, Altera A, Salmi A, Vanini V, Cuzzi G, Arlehamn C Front Immunol. 2025; 15:1484143.
PMID: 39872515 PMC: 11770028. DOI: 10.3389/fimmu.2024.1484143.
Panda S, Morgan J, Cheng C, Saito M, Gilman R, Ciobanu N Nat Commun. 2024; 15(1):765.
PMID: 38278794 PMC: 10817963. DOI: 10.1038/s41467-024-45058-9.
Moyo-Gwete T, Richardson S, Keeton R, Hermanus T, Spencer H, Manamela N PLoS Pathog. 2023; 19(11):e1011772.
PMID: 37943890 PMC: 10684107. DOI: 10.1371/journal.ppat.1011772.
Foreman T, Nelson C, Sallin M, Kauffman K, Sakai S, Otaizo-Carrasquero F J Exp Med. 2023; 220(8).
PMID: 37097292 PMC: 10130742. DOI: 10.1084/jem.20222090.
Parween F, Singh S, Zhang H, Kathuria N, Otaizo-Carrasquero F, Shamsaddini A bioRxiv. 2023; .
PMID: 36789428 PMC: 9928044. DOI: 10.1101/2023.01.25.525561.